Saturday, June 7, 2025

Monthly Archives: June, 2020

Complete results from study of Pfizer’s abrocitinib published in jama dermatology

June 03, 2020: "Pfizer Inc. announced that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an...

Roche’s Elecsys IL-6 test receives FDA Authorisation for severe inflammatory response

June 04, 2020: "Roche announced that the U.S. FDA has issued an Emergency Use Authorisation (EUA) for the Elecsys® IL-6 test. This test measures...

Sanofi to launch “Action 2020” stock purchase plan

June 3, 2020: "Sanofi announces the launch of “Action 2020” on June 8, 2020, a worldwide stock purchase plan reserved for its employees, which...

Coronavirus (COVID-19) Update: Daily Roundup June 2, 2020

June 02, 2020:"The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The agency issued...

Pfizer Establishes New Program To Support Continued Biotechnology Innovation

June 02, 2020: "Pfizer announced that the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in...

Novartis provides an update on FDA review of ofatumumab for relapsing multiple sclerosis

June 02, 2020: "Novartis announced that it has received notice from the US FDA that the agency has extended its review of the Supplemental...

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ for Psoriatic Arthritis

June 1, 2020: "AbbVie, a research-based global biopharmaceutical company, today announced that it has submitted applications for a new indication to the U.S. FDA...

AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors

 June 01, 2020: "AbbVie, a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company announced that a global, strategic collaboration to develop...

Coronavirus (COVID-19) Update: Daily Roundup June 1, 2020

June 02, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On May...

EC approves Sarclisa® for adults with relapsed and refractory multiple myeloma

June 02, 2020: The EC has approved Sarclisa® (isatuximab) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adult patients with relapsed and...

Sanofi to present oncology strategy: Update on portfolio and emerging pipeline

June 02, 2020: "Sanofi Chief Executive Officer Paul Hudson along with R&D and commercial leaders will provide an overview of Sanofi’s oncology strategy and...

FDA Ok’s Roche’s Tecentriq in combination with Avastin for liver cancer

June 02, 2020: "Roche announced that the US FDA has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with...
- Advertisment -

Most Read